122 related articles for article (PubMed ID: 14984716)
1. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model.
Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Fournadjiev J; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Leon MB; Moses JW; Iversen P
Cardiovasc Radiat Med; 2003; 4(3):152-9. PubMed ID: 14984716
[TBL] [Abstract][Full Text] [Related]
2. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Colombo A; Leon MB; Moses JW; Iversen P
Catheter Cardiovasc Interv; 2005 Mar; 64(3):389-94. PubMed ID: 15736246
[TBL] [Abstract][Full Text] [Related]
3. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
Kipshidze NN; Iversen P; Kim HS; Yiazdi H; Dangas G; Seaborn R; New G; Tio F; Waksman R; Mehran R; Tsapenko M; Stone GW; Roubin GS; Iyer S; Leon MB; Moses JW
Catheter Cardiovasc Interv; 2004 Apr; 61(4):518-27. PubMed ID: 15065150
[TBL] [Abstract][Full Text] [Related]
4. Targeted vascular delivery of antisense molecules using intravenous microbubbles.
Porter TR; Xie F; Knapp D; Iversen P; Marky LA; Tsutsui JM; Maiti S; Lof J; Radio SJ; Kipshidze N
Cardiovasc Revasc Med; 2006; 7(1):25-33. PubMed ID: 16513520
[TBL] [Abstract][Full Text] [Related]
5. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
Koutouzis M; Papalois A; Kyrzopoulos S; Dafnomili P; Kyriakides ZS
Cardiol J; 2008; 15(5):458-62. PubMed ID: 18810722
[TBL] [Abstract][Full Text] [Related]
6. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model.
Carter AJ; Aggarwal M; Kopia GA; Tio F; Tsao PS; Kolata R; Yeung AC; Llanos G; Dooley J; Falotico R
Cardiovasc Res; 2004 Sep; 63(4):617-24. PubMed ID: 15306217
[TBL] [Abstract][Full Text] [Related]
8. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
[TBL] [Abstract][Full Text] [Related]
9. In vivo distribution of c-myc antisense oligodeoxynucleotides local delivered by gelatin-coated platinum-iridium stents in rabbits and its effect on apoptosis.
Zhang XX; Cui CC; Xu XG; Hu XS; Fang WH; Kuang BJ
Chin Med J (Engl); 2004 Feb; 117(2):258-63. PubMed ID: 14975213
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
[TBL] [Abstract][Full Text] [Related]
11. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
12. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
[TBL] [Abstract][Full Text] [Related]
13. Local paclitaxel delivery after coronary stenting in an experimental animal model.
Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
[TBL] [Abstract][Full Text] [Related]
14. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
15. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
16. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model.
Hou D; Narciso H; Kamdar K; Zhang P; Barclay B; March KL
Cardiovasc Intervent Radiol; 2005; 28(1):60-5. PubMed ID: 15719180
[TBL] [Abstract][Full Text] [Related]
17. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on antisense therapy for the prevention of restenosis.
Kipshidze N; Moses J; Shankar LR; Leon M
Curr Opin Mol Ther; 2001 Jun; 3(3):265-77. PubMed ID: 11497351
[TBL] [Abstract][Full Text] [Related]
19. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model.
New G; Moses JW; Roubin GS; Leon MB; Colombo A; Iyer SS; Tio FO; Mehran R; Kipshidze N
Catheter Cardiovasc Interv; 2002 Oct; 57(2):266-71. PubMed ID: 12357534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]